Arch Capital Group (NASDAQ:ACGL) Price Target Raised to $106.00 at Barclays

Key Points

• Barclays raised its price target on Arch Capital to $106 (from $104) with an "equal weight" rating, implying about an 8.05% upside; the stock's consensus analyst target is roughly $109.40 with a mixed slate of 9 Buys, 8 Holds and 1 Sell.
• Arch reported strong quarterly results, beating estimates with $2.98 EPS (vs. $2.34 expected) and $4.93 billion in revenue, and analysts now forecast about 8.42 EPS for the year.
• Insider selling and valuation notes: CEO Nicolas Papadopoulo sold 21,930 shares and insiders sold 78,267 shares (~$7.29M) in the last 90 days; shares traded around $98.10, market cap ~$34.95B and a P/E of 8.44, while institutions own ~89.1% of the stock.

Arch Capital Group (NASDAQ:ACGL - Get Free Report) had its price target lifted by analysts at Barclays from $104.00 to $106.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an "equal weight" rating on the insurance provider's stock. Barclays's price objective suggests a potential upside of 8.05% from the company's current price.

Several other analysts also recently issued reports on the stock. Keefe, Bruyette & Woods lifted their price target on shares of Arch Capital Group from $104.00 to $105.00 and gave the company a "market perform" rating in a research report on Tuesday. Wells Fargo & Company lifted their price target on shares of Arch Capital Group from $106.00 to $109.00 and gave the company an "overweight" rating in a research report on Wednesday, February 11th. UBS Group reissued a "buy" rating and issued a $114.00 price target (up from $113.00) on shares of Arch Capital Group in a research report on Tuesday, February 17th. Royal Bank Of Canada lifted their price target on shares of Arch Capital Group from $108.00 to $115.00 and gave the company an "outperform" rating in a research report on Wednesday, February 11th. Finally, Mizuho lifted their price target on shares of Arch Capital Group from $95.00 to $102.00 and gave the company a "neutral" rating in a research report on Thursday, February 12th. Nine equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $109.40.

Arch Capital Group Trading Up 1.2%

Shares of ACGL stock traded up $1.18 during trading hours on Wednesday, hitting $98.10. 295,906 shares of the company were exchanged, compared to its average volume of 1,979,360. The firm has a market cap of $34.95 billion, a P/E ratio of 8.44, a P/E/G ratio of 3.94 and a beta of 0.41. Arch Capital Group has a fifty-two week low of $82.44 and a fifty-two week high of $103.39. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.53 and a current ratio of 0.53. The company has a 50 day simple moving average of $96.78 and a two-hundred day simple moving average of $93.52.

Arch Capital Group (NASDAQ:ACGL - Get Free Report) last announced its quarterly earnings data on Monday, February 9th. The insurance provider reported $2.98 EPS for the quarter, topping the consensus estimate of $2.34 by $0.64. Arch Capital Group had a net margin of 22.07% and a return on equity of 16.73%. The company had revenue of $4.93 billion during the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter last year, the firm posted $2.26 EPS. Equities analysts anticipate that Arch Capital Group will post 8.42 EPS for the current year.

Insider Buying and Selling

In other news, CEO Nicolas Papadopoulo sold 21,930 shares of the company's stock in a transaction on Tuesday, March 10th. The shares were sold at an average price of $96.31, for a total value of $2,112,078.30. Following the completion of the sale, the chief executive officer owned 871,594 shares in the company, valued at $83,943,218.14. This represents a 2.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Brian S. Posner sold 3,000 shares of the company's stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $17.11, for a total transaction of $51,330.00. Following the completion of the sale, the director owned 2,000 shares of the company's stock, valued at approximately $34,220. The trade was a 60.00% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 78,267 shares of company stock valued at $7,291,637 in the last 90 days. Insiders own 4.10% of the company's stock.

Institutional Trading of Arch Capital Group

Several institutional investors have recently made changes to their positions in ACGL. Geneos Wealth Management Inc. grew its stake in shares of Arch Capital Group by 157.9% in the 1st quarter. Geneos Wealth Management Inc. now owns 673 shares of the insurance provider's stock worth $65,000 after acquiring an additional 412 shares in the last quarter. Sivia Capital Partners LLC bought a new stake in shares of Arch Capital Group in the 2nd quarter worth $253,000. CW Advisors LLC grew its stake in shares of Arch Capital Group by 6.5% in the 2nd quarter. CW Advisors LLC now owns 3,098 shares of the insurance provider's stock worth $282,000 after acquiring an additional 189 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Arch Capital Group by 366.6% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,790 shares of the insurance provider's stock worth $254,000 after acquiring an additional 2,192 shares in the last quarter. Finally, Baird Financial Group Inc. grew its stake in shares of Arch Capital Group by 9.0% in the 2nd quarter. Baird Financial Group Inc. now owns 54,963 shares of the insurance provider's stock worth $5,004,000 after acquiring an additional 4,544 shares in the last quarter. Institutional investors own 89.07% of the company's stock.

About Arch Capital Group

Arch Capital Group Ltd. NASDAQ: ACGL is a Bermuda-based insurance and reinsurance holding company that underwrites a broad range of property and casualty, mortgage, and specialty risk products. The company operates through a group of underwriting subsidiaries and platforms to provide insurance, reinsurance and related risk solutions tailored to commercial, institutional and individual clients.

Arch's product mix includes treaty and facultative reinsurance, primary casualty and property insurance, mortgage insurance and other specialty lines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.